Bon Natural Life Limited (BON)
BON trades on Nasdaq in Health Care, Medicinal Chemicals and Botanical Products . Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.12
-0.76% on the day
Market cap
$9.1M
Nano cap
Revenue · 2025
$18.7M
-21.7% on 2024
Net income · 2025
-$2.0M
-10.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | BON on Nasdaq |
| Sector | Health Care |
| Industry | Medicinal Chemicals and Botanical Products |
| Country | China |
| IPO year | 2021 |
| SEC CIK | 0001816815 |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $18.7M |
| Net income | -$2.0M |
| Operating income | -$1.6M |
| Net margin | -10.7% |
| Operating margin | -8.7% |
| Revenue growth | -21.7% |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2025-10-16 |
| Latest annual report | 20-F | 2026-01-23 |
| Latest quarterly / interim | 6-K | 2026-09-23 |
Source: SEC EDGAR submissions feed, 152 recent filings. All filings on EDGAR.
Peers in Medicinal Chemicals and Botanical Products
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NAII | Natural Alternatives International Inc. | $1.15 | -5.74% | $7.2M |
| MTEX | Mannatech Incorporated | $7.56 | -2.95% | $14.6M |
| AKAN | Akanda Corp. Common Shares | $1.38 | -15.85% | $3.3M |
| IMCC | IM Cannabis Corp. Common Shares | $1.36 | -6.85% | $2.2M |
| BTMD | Biote Corp. | $1.04 | -8.77% | $37.4M |
| ISPR | Ispire Technology Inc. | $1.45 | -1.36% | $83.7M |
| FTLF | FitLife Brands Inc. | $9.07 | -1.73% | $85.2M |
| MDWD | MediWound Ltd. | $12.22 | -2.71% | $157.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier